4//SEC Filing
Tatsis Ourania 4
Accession 0000875320-25-000135
CIK 0000875320other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:48 PM ET
Size
6.1 KB
Accession
0000875320-25-000135
Insider Transaction Report
Form 4
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
Transactions
- Sale
Common Stock
2025-02-27$475.34/sh−530$251,930→ 58,539 total - Tax Payment
Common Stock
2025-02-26$479.61/sh−4,962$2,379,825→ 59,069 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 02/29/2024.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001789815
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:48 PM ET
- Size
- 6.1 KB